SurgePays, Inc. Common Stock
Here’s whether SurgePays, Inc. Common Stock (SURG) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.
Positives: RSI 44 — healthy momentum range. Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-14.61% over 10 days); weak 1-year return of -92.7%; 3-month momentum negative (-66.0%); rising volume on a downtrend (distribution, 1.61x avg). Currently 94.6% off its 52-week high. Score: -5/7.
SURG is trading below its 200-day MA ($0.95) — a key warning sign the longer-term trend is under pressure. An RSI of 44.3 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -92.7% compares to +20.5% for SPY (trailed the market by 113.2%). The current 94.6% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.